ArticleCancer research2022

EGFR Inhibition Enhances the Cellular Uptake and Antitumor-Activity of the HER3 Antibody-Drug Conjugate HER3-DXd.

Heidi M Haikala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.